Skip to main content
. 2019 Oct 10;17:339. doi: 10.1186/s12967-019-2087-9

Fig. 1.

Fig. 1

The study methodology overview and verification. a Cell-free DNA (cfDNA) was extracted from blood samples which were collected from 32 lung cancer patients during each chemotherapy cycle. Square with light scarlet referred to the first-line treatment: platinum-based chemotherapy. b Gene collections of Oseq-ctDNA panel which involves 508 cancer-related genes. c Bioinformatic pipeline for candidate mutations detecting. d Landscape of genetic alterations between 27 pre-chemotherapy samples and TCGA cohort. A bar represented one of six substitution subtypes with different colors. The y-axis represented mutated proportion